Authors
Loading...
Engineered nanoparticles improve immunogenic cell death and reshape the tumor microenvironment, suggesting new HCC therapies.
Luo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: